3 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Myeloid Leukemia: new trials by email Literature Review of Myeloid Leukemia trials Research Report on Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Halt Aging in Survivors of Blood Cancers Behavioral Coaching Intervention, Virtual Exercise Platform - Hematological Malignancy, Leukemia | Not applicable | Recruiting | University of Nebraska | 180 | 2026-04-09 | 2026-07-01 |
| Integrated Actionable Aging Assessment for Cancer Patients Pilot Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH - Breast Cancer, Hodgkin Lymphoma | Not applicable | Active not recruiting | University of Colorado, Denver | 35 | 2024-03-01 | 2026-11-03 |
| Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery Behavioral techniques - Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Not applicable | Completed | University of Wisconsin, Madison | 39 | 2016-12-22 | 2019-11-15 |
| Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation Behavioral techniques - Hodgkin's Lymphoma, Leukemia | Not applicable | Completed | University of Wisconsin, Madison | 17 | 2016-03-01 | 2019-11-15 |
| Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine blood samples, azacytidine - Myeloid Leukemia, Myelodysplastic Syndromes | Not applicable | Unknown | Assistance Publique Hopitaux De Marseille | 35 | 2015-08-01 | 2015-07-03 |
| Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT Busulfan-Cyclophosphamide as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide-Busulfan as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation - Myeloid Leukemia, Precursor Myeloid Neoplasms | Not applicable | Completed | University Hospital, Basel, Switzerland | 72 | 2013-01-01 | 2018-03-02 |
Leukemia, Myeloid (6) · Hodgkin Disease (4) · Leukemia, Lymphoid (4) · Multiple Myeloma (4) · Leukemia (3) · Lymphoma, Non-Hodgkin (3) · Myelodysplastic Syndromes (3) · Depression (2) · Fatigue (2) · Leukemia, Monocytic, Acute (2) · Sleep Initiation and Maintenance Disorders (2) · Breast Neoplasms (1) · Hematologic Neoplasms (1) · Kidney Neoplasms (1) · Prostatic Neoplasms (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Blood Protein Disorders (4) · Cardiovascular Diseases (4) · Hemorrhagic Disorders (4) · Hemostatic Disorders (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoproliferative Disorders (4) · Neoplasms, Plasma Cell (4) · Paraproteinemias (4)
Behavior Therapy (2) · Azacitidine (1) · Blood Specimen Collection (1) · Social Determinants of Health (1)
University of Wisconsin, Madison (2) · Assistance Publique Hopitaux De Marseille (1) · University Hospital, Basel, Switzerland (1) · University of Colorado, Denver (1) · University of Nebraska (1)
United States (4) · France (1) · Switzerland (1)
Erin Costanzo (1) · Erin Costanzo, MD (1) · Gayathri Nair, MD (1) · Jakob Passweg, MD (1) · Nathan Cantoni, MD (1) · Russell E Glasgow (1) · Sabine Gerull, MD (1) · Vijaya Raj Bhatt, MBBS,MS (1) · Yves Chalandon, MD (1)
4UL1TR000427-10 (2), P30CA014520 (2), K07CA136966 (1), P50CA244688 (1)